cells until IL-2 concentrations have decreased. An inhibitory effect of IL-2 on the formation of T FR cells has also reported in another study 8 . IL-2 suppresses the development of T FH cells by inducing phosphorylation of the transcription factor STAT5, a mechanism that is dependent on expression of the transcriptional repressor Blimp-1 (ref. 2) . Blimp-1 limits the size of the T FR cell population in a cell-intrinsic way 4 , and, interestingly, enhancing the availability of IL-2 in Blimp-1-deficient cells does not inhibit the accumulation of T FR cells, which suggests that an IL-2-STAT5-Blimp-1 axis represses the differentiation of T FR cells. However, not all Blimp-1-negative T reg cells are T FR cells, which indicates that other signaling events need to be delivered in parallel with the withdrawal of IL-2 before a T reg cell is able to become a T FR cell 3 .
Intriguingly, infection with influenza virus yields IL-2 concentrations sufficient to inhibit the differentiation of T FR cells but not that of T FH cells 3 . This difference in responses to IL-2 might transpire because the precursors of T FR cells are more sensitive to IL-2 than are the precursors of T FH cells, due to higher CD25 expression. CD25 is expressed by the majority of T reg cells, and signaling via this receptor is essential for their survival and population expansion under homeostatic conditions 9 . However, like T FR cells, some T reg cells do not express CD25; T reg cells that express T-bet, the transcriptional regulator of the T H 1 subset of helper T cells, and T reg cells with an effectormemory phenotype also have downregulated CD25 expression 10, 11 . Together these studies might intimate a model in which 'naive' T reg cells require IL-2 signaling for their maintenance, but that limiting IL-2 signaling is essential for T reg cells to differentiate into effector subsets or memory T reg cells.
The role of T FR cells in GC biology has been difficult to delineate, with multiple studies yielding conflicting results. Initially this was because there was no mouse model that specifically lacked T FR cells. Because of this, all in vivo experiments were performed using mixed-bone marrow chimeras or adoptive cell transfer-systems that have limitations. 
cells (T FH cells) for their formation and maintenance. Follicular T cells include a population of Foxp3 + follicular regulatory T cells (T FR cells) whose biology has remained enigmatic since their discovery in 2011 (ref. 2).
In this issue of Nature Immunology, Ballesteros-Tato and colleagues demonstrate an inhibitory role for interleukin 2 (IL-2) in the differentiation of T FR cells and show that preventing such differentiation results in increased production of antibody-secreting plasma cells, including those with self-reactive specificity 3 .
In contrast to T FH cells, which provide help to GC B cells, T FR cells have a suppressive function and are thought to limit the GC response. Despite their regulatory ability, T FR cells resemble T FH cells phenotypically, expressing the chemokine receptor CXCR5 and costimulatory molecule PD-1, as well as Bcl-6, the transcription factor that is essential for the differentiation of both T FH cells and T FR cells 4-6 . One feature common to both T FH cells and T FR cells is that they do not express CD25, the α-chain of the high-affinity IL-2 receptor 4, 7, 8 . In primed CD4 + T cells, signaling via CD25 inhibits Bcl-6 expression and thereby prevents the differentiation of T FH cells 2 . However, it is not clear why T FR cells do not express CD25; this is especially paradoxical because Foxp3 + regulatory T cells (T reg cells) require IL-2 signaling for their maintenance. Ballesteros-Tato and colleagues now show that abundance of IL-2 also suppresses the differentiation of T FR cells 3 (Fig. 1) . In the context of infection with influenza virus, this mechanism delays the differentiation of T FR cells from Foxp3 + precursor T FR cells trump autoimmune antibody responses to limit sedition
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The differentiation of follicular regulatory T cells can be limited by the cytokine IL-2, preventing the emergence of autoantibodies. This research identifies these cells as key regulators of the germinal center response.
mice (in which loxP-flanked Bcl6 alleles are deleted by Cre recombinase expressed from Foxp3) has provided a mouse that specifically lacks T FR cells 12 . Ballesteros-Tato and colleagues use this model to demonstrate that T FR cells control the formation of antibodysecreting cells 3 . This dysregulation in the absence of T FR cells is not due simply to a change in magnitude of the response, as the antibody specificity is also altered: the lack of T FR cells does not alter the titers of antibodies to influenza virus but increases the Antibody and T cell responses are critical for the host control of DENV infection and long-term protection. However, in a subset of infected people, severe immunopathologies arise. Severe disease occurs most commonly during sequential infection with distinct DENV serotypes and manifests as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). These diseases are thought to be elicited by excessive activation of immune cells and a 'cytokine storm' that induce a variety of clinical signs, including endothelial permeability and severe vascular leakage 2 . Although the immunological parameters that underpin severe DHF and DSS have not been fully elucidated, the 'original antigenic sin' phenomena have been proposed to contribute to the disease process. The hypothesis of original antigenic sin postulates that antibody and T cell responses of high avidity are generated during primary infection. During the secondary heterologous exposure, changes to the targeted epitopes cause those same antibodies and lymphocytes to be of low avidity and have poor functional ability. Nevertheless, the presence of an accelerated memory response outcompetes the naive production of anti-nuclear autoimmune antibodies after infection with influenza virus. Consistent with the proposal of a role for IL-2 in limiting the formation of T FR cells, treating mice with recombinant IL-2 also results in autoantibody production 3 .
The finding that T FR cells limit the production of self-reactive antibody-secreting plasma cells is a key discovery in understanding the biology of these cells. Within the GC, B cells undergo somatic hypermutation of the genes encoding their B cell receptors. This mutation process is random and can result in the emergence of self-reactive clones. It is therefore essential that the selection of mutated GC B cells is stringent to ensure that these cells do not exit the GC as long-lived plasma cells or memory B cells. Selection within the GC is a process thought to be driven through positive feedback to B cells from follicular dendritic cells and T FH cells, while self-reactive B cells perish through neglect 1 . The discovery that in the absence of T FR cells, B cells with a selfreactive B cell receptor can emerge from the GC suggests that these cells might have an active role in negative B cell selection. Alternatively, T FR cells might act to limit the provision of positive signals from either T FH cells or follicular dendritic cells. The mechanism by which T FR cells control autoreactivity from the GC and the main cell types on which they act are pertinent questions in understanding not just the role of T FR cells but also the biology of the GC. D engue virus (DENV), the etiological agent of dengue fever, is a mosquitoborne flavivirus that infects nearly 400 million people every year. Primary infection with any of the four DENV serotypes (DENV1-DENV4) can cause dengue fever, an acute self-limiting febrile illness that normally results in lifelong serotype-specific immunity. Secondary exposure to heterologous DENV serotypes, however, is the main risk factor for severe disease, which might result from poorly functioning humoral and cellular responses generated during the primary infection 1, 2 . In this issue of Nature Immunology, Culshaw et al. reveal an unusual immunodominant, DENVspecific CD8 + T cell response biased by T cell antigen receptor (TCR) β-chain variable region (TRBV) that arises despite the T cells' weak affinity for antigens derived from both the primary DENV infection and the secondary DENV infection 3 . The recognition of ligand by these TRBV11-2 + T cells is predicated on the contact of a germline-encoded residue of complementarity-determining region CDR2β immune response of higher avidity 4,5 . To contribute to dysfunctional DENV immunity, the antibody and memory lymphocyte responses of low avidity should be suboptimal, which allows viremia to develop, with the ensuing overzealous or altered T cell responses inducing immunopathology.
Several key observations suggest that cross-serotype-reactive antibody and T cell responses of weak avidity contribute to DHF and DSS. High affinity antibodies targeting the primary DENV serotype have been observed to weakly cross-react and fail to neutralize heterologous DENV serotypes. Some of these antibodies can induce antibody-dependent enhancement, which might drive higher viral loads in people. Antibodydependent enhancement occurs when nonneutralizing DENV-specific antibodies of weak avidity or low concentration opsonize the virus, which allows Fcγ-receptor-mediated uptake of the virus into monocytes or macrophages and thereby increases infection and production of the virus 1 . Furthermore, severe disease symptoms correlate with a rapidly decreasing viral load and peak secretion of pro-inflammatory cytokines, hallmarks of an ongoing acute T cell response 2 . Coincident with the heterologous infection, T cell responses reactive to the primary and secondary DENV serotypes expand. Some of these T cells are serotype cross-reactive with n E W s A n d v I E W s
